168 related articles for article (PubMed ID: 25537341)
1. Immunomodulatory effects of a low-dose clarithromycin-based macrolide solution pressurised metered dose inhaler.
Haghi M; Saadat A; Zhu B; Colombo G; King G; Young PM; Traini D
Pharm Res; 2015 Jun; 32(6):2144-53. PubMed ID: 25537341
[TBL] [Abstract][Full Text] [Related]
2. The formulation of a pressurized metered dose inhaler containing theophylline for inhalation.
Zhu B; Haghi M; Goud M; Young PM; Traini D
Eur J Pharm Sci; 2015 Aug; 76():68-72. PubMed ID: 25956075
[TBL] [Abstract][Full Text] [Related]
3. Biological Effects of Simvastatin Formulated as pMDI on Pulmonary Epithelial Cells.
Tulbah AS; Ong HX; Lee WH; Colombo P; Young PM; Traini D
Pharm Res; 2016 Jan; 33(1):92-101. PubMed ID: 26238046
[TBL] [Abstract][Full Text] [Related]
4. The formulation, chemical and physical characterisation of clarithromycin-based macrolide solution pressurised metered dose inhaler.
Saadat A; Zhu B; Haghi M; King G; Colombo G; Young PM; Traini D
J Pharm Pharmacol; 2014 May; 66(5):639-45. PubMed ID: 24329164
[TBL] [Abstract][Full Text] [Related]
5. Is the cellular uptake of respiratory aerosols delivered from different devices equivalent?
Ong HX; Traini D; Loo CY; Sarkissian L; Lauretani G; Scalia S; Young PM
Eur J Pharm Biopharm; 2015 Jun; 93():320-7. PubMed ID: 25930239
[TBL] [Abstract][Full Text] [Related]
6. Inhalable Clarithromycin Microparticles for Treatment of Respiratory Infections.
Dimer F; de Souza Carvalho-Wodarz C; Haupenthal J; Hartmann R; Lehr CM
Pharm Res; 2015 Dec; 32(12):3850-61. PubMed ID: 26113237
[TBL] [Abstract][Full Text] [Related]
7. Use of functional respiratory imaging to characterize the effect of inhalation profile and particle size on lung deposition of inhaled corticosteroid/long-acting β2-agonists delivered via a pressurized metered-dose inhaler.
Van Holsbeke C; De Backer J; Vos W; Marshall J
Ther Adv Respir Dis; 2018; 12():1753466618760948. PubMed ID: 29499614
[TBL] [Abstract][Full Text] [Related]
8. Towards the bioequivalence of pressurised metered dose inhalers 2. Aerodynamically equivalent particles (with and without glycerol) exhibit different biopharmaceutical profiles in vitro.
Haghi M; Bebawy M; Colombo P; Forbes B; Lewis DA; Salama R; Traini D; Young PM
Eur J Pharm Biopharm; 2014 Jan; 86(1):38-45. PubMed ID: 23528797
[TBL] [Abstract][Full Text] [Related]
9. In vitro cell integrated impactor deposition methodology for the study of aerodynamically relevant size fractions from commercial pressurised metered dose inhalers.
Haghi M; Traini D; Young P
Pharm Res; 2014 Jul; 31(7):1779-87. PubMed ID: 24549816
[TBL] [Abstract][Full Text] [Related]
10. Steroid/mucokinetic hybrid nanoporous microparticles for pulmonary drug delivery.
Tewes F; Paluch KJ; Tajber L; Gulati K; Kalantri D; Ehrhardt C; Healy AM
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):604-13. PubMed ID: 23563102
[TBL] [Abstract][Full Text] [Related]
11. Modelling the bronchial barrier in pulmonary drug delivery: A human bronchial epithelial cell line supplemented with human tracheal mucus.
Murgia X; Yasar H; Carvalho-Wodarz C; Loretz B; Gordon S; Schwarzkopf K; Schaefer U; Lehr CM
Eur J Pharm Biopharm; 2017 Sep; 118():79-88. PubMed ID: 28373109
[TBL] [Abstract][Full Text] [Related]
12. Clarithromycin prevents human respiratory syncytial virus-induced airway epithelial responses by modulating activation of interferon regulatory factor-3.
Yamamoto K; Yamamoto S; Ogasawara N; Takano K; Shiraishi T; Sato T; Miyata R; Kakuki T; Kamekura R; Kojima T; Tsutsumi H; Himi T; Yokota SI
Pharmacol Res; 2016 Sep; 111():804-814. PubMed ID: 27468646
[TBL] [Abstract][Full Text] [Related]
13. Long-term treatment of clarithromycin at a low concentration improves hydrogen peroxide-induced oxidant/antioxidant imbalance in human small airway epithelial cells by increasing Nrf2 mRNA expression.
Iwayama K; Kusakabe A; Ohtsu K; Nawano T; Tatsunami R; Ohtaki KI; Tampo Y; Hayase N
BMC Pharmacol Toxicol; 2017 Feb; 18(1):15. PubMed ID: 28235416
[TBL] [Abstract][Full Text] [Related]
14. Factors affecting solubility and penetration of clarithromycin through gastric mucus.
Grübel P; Cave DR
Aliment Pharmacol Ther; 1998 Jun; 12(6):569-76. PubMed ID: 9678818
[TBL] [Abstract][Full Text] [Related]
15. Clinical equivalence of budesonide dry powder inhaler and pressurized metered dose inhaler.
Srichana T; Juthong S; Thawithong E; Supaiboonpipat S; Soorapan S
Clin Respir J; 2016 Jan; 10(1):74-82. PubMed ID: 25043636
[TBL] [Abstract][Full Text] [Related]
16. A new therapeutic avenue for bronchiectasis: Dry powder inhaler of ciprofloxacin nanoplex exhibits superior ex vivo mucus permeability and antibacterial efficacy to its native ciprofloxacin counterpart.
Tran TT; Vidaillac C; Yu H; Yong VFL; Roizman D; Chandrasekaran R; Lim AYH; Low TB; Tan GL; Abisheganaden JA; Koh MS; Teo J; Chotirmall SH; Hadinoto K
Int J Pharm; 2018 Aug; 547(1-2):368-376. PubMed ID: 29886096
[TBL] [Abstract][Full Text] [Related]
17. The interaction of dendrimer-doxorubicin conjugates with a model pulmonary epithelium and their cosolvent-free, pseudo-solution formulations in pressurized metered-dose inhalers.
Zhong Q; Humia BV; Punjabi AR; Padilha FF; da Rocha SRP
Eur J Pharm Sci; 2017 Nov; 109():86-95. PubMed ID: 28774811
[TBL] [Abstract][Full Text] [Related]
18. New co-spray-dried tobramycin nanoparticles-clarithromycin inhaled powder systems for lung infection therapy in cystic fibrosis patients.
Pilcer G; Rosière R; Traina K; Sebti T; Vanderbist F; Amighi K
J Pharm Sci; 2013 Jun; 102(6):1836-1846. PubMed ID: 23568616
[TBL] [Abstract][Full Text] [Related]
19. Systematic review of clinical effectiveness of pressurised metered dose inhalers versus other hand held inhaler devices for delivering beta (2 )agonists bronchodilators in asthma.
Ram FS; Wright J; Brocklebank D; White JE
BMJ; 2001 Oct; 323(7318):901-5. PubMed ID: 11668134
[TBL] [Abstract][Full Text] [Related]
20. In vitro investigation on the impact of airway mucus on drug dissolution and absorption at the air-epithelium interface in the lungs.
Cingolani E; Alqahtani S; Sadler RC; Prime D; Stolnik S; Bosquillon C
Eur J Pharm Biopharm; 2019 Aug; 141():210-220. PubMed ID: 31154066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
